PAL palla pharma limited
Add to My Watchlist 0.00% ! 29.5¢

News: PAL Palla Pharma Says Expects To Be EBITDA Positive From Q1 Fy21

  1. Hot News
    193,698 Posts.
    lightbulb Created with Sketch. 2825
    clock Created with Sketch.
    06/11/20
    09:40
    Post #: 48680375

    Nov 6 (Reuters) - Palla Pharma Ltd (PAL) :

    • EXPECTS TO BE EBITDA POSITIVE FROM Q1 FY21
    • EXPECTS NEGATIVE EBITDA PERFORMANCE FOR FY20
    • NEGOTIATED EXTENSION OF WORKING CAPITAL DEBT FACILITY WITH WASHINGTON H. SOUL PATTINSON & CO LTD
    • KEY TERMS OF AMENDED FACILITY INCLUDE TEMPORARY LIMIT INCREASE TO $20 MILLION
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch. 1  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AII Building assets, producing critical minerals and slashing dependency on China
right-arrow Created with Sketch.
NEWS Gold producers Alkane and Mandalay make merger official
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.